Increased environmental exposure to iodine from dietary or therapeutic sources may contribute to the escalating prevalence of autoimmune thyroiditis in humans. Highly iodinated thyroglobulin, the 660 Kd glycoprotein major storage form of thyroid hormones, due to increased iodine intake, has been associated with increased incidence and severity of spontaneous autoimmune thyroiditis in chickens and in the diabetes- prone lymphocytic thyroiditis-associated BB/W rat. Clinical observations in humans also associate excess iodine as a potentiator of autoimmune thyroid disease, but no experimental information about the pathogenesis in humans is available. The role of iodine in a multifactorial autoimmune disease like chronic lymphocytic thyroiditis is a factor that has too frequently been neglected and may account for many of the differences in frequency of autoimmune thyroid disease among geographical areas. We propose to explore the differences in the immune response to thyroglobulin and its fragments iodinated to varying degrees between patients suffering from autoimmune thyroid disease compared to euthyroid individuals with thyroid autoantibodies. First, studies will concentrate on the preparation, iodination, isolation, and identification of the relevant thyroglobulin and its fragments. Tryptic- digest peptide maps resolved by HPLC will enable us to compare patterns of iodination among the various Tg preparations. Second, we propose, to evaluate cellular human immune response to variously iodinated thyroglobulin or its fragments. The functional responses of human lymphocytes to variously iodinated thyroglobulin and its fragments will be tested by means of cell proliferation assays. We will develop a series of T cell lines/clones to test the fine specificities of the cellular response. We will then investigate markers of cellular proliferation (e.g. IL-2, IL-4 secretion) to pinpoint the specific stage at which the thyroglobulin or its fragments is playing a role. The ultimate goal is to understand the immunotoxic role of iodine in inducing autoimmune thyroid disease with the hope of developing preventive strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042174-02
Application #
3243235
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1992-04-01
Project End
1995-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Burek, C Lynne; Talor, Monica V (2009) Environmental triggers of autoimmune thyroiditis. J Autoimmun 33:183-9
Barin, J G; Talor, M V; Sharma, R B et al. (2005) Iodination of murine thyroglobulin enhances autoimmune reactivity in the NOD.H2 mouse. Clin Exp Immunol 142:251-9
Sharma, Rajni B; Alegria, Judy D; Talor, Monica V et al. (2005) Iodine and IFN-gamma synergistically enhance intercellular adhesion molecule 1 expression on NOD.H2h4 mouse thyrocytes. J Immunol 174:7740-5
Bonita, Raphael E; Rose, Noel R; Rasooly, Linda et al. (2003) Kinetics of mononuclear cell infiltration and cytokine expression in iodine-induced thyroiditis in the NOD-H2h4 mouse. Exp Mol Pathol 74:1-12
Barin, Jobert G; Afanasyeva, Marina; Talor, Monica V et al. (2003) Thyroid-specific expression of IFN-gamma limits experimental autoimmune thyroiditis by suppressing lymphocyte activation in cervical lymph nodes. J Immunol 170:5523-9
Rose, Noel R; Bonita, Raphael; Burek, C Lynne (2002) Iodine: an environmental trigger of thyroiditis. Autoimmun Rev 1:97-103
Bonita, Raphael E; Rose, Noel R; Rasooly, Linda et al. (2002) Adhesion molecules as susceptibility factors in spontaneous autoimmune thyroiditis in the NOD-H2h4 mouse. Exp Mol Pathol 73:155-63
Butscher, W G; Ladenson, P W; Burek, C L (2001) Whole-blood proliferation assay for autoimmune thyroid disease: comparison to density-gradient separated-peripheral blood lymphocytes. Thyroid 11:531-7
Rose, N R; Burek, C L (2000) Autoantibodies to thyroglobulin in health and disease. Appl Biochem Biotechnol 83:245-51; discussion 251-4, 297-3
Saboori, A M; Rose, N R; Yuhasz, S C et al. (1999) Peptides of human thyroglobulin reactive with sera of patients with autoimmune thyroid disease. J Immunol 163:6244-50

Showing the most recent 10 out of 26 publications